Captopril reduces interstitial renal fibrosis and preserves more normal renal tubules in neonatal dogs with partial urethral obstruction: a preliminary study.

Chronic renal damage due to tubulointerstitial fibrosis is one of several complications of posterior urethral valves in a significant number of children. As activation of the renin-angiotensin system plays an important role in this injury, we conducted this study to investigate whether administration of captopril reduced renal fibrosis in an experimental model using partial urethral obstruction (PUO) in neonatal dogs.
Experimental PUO was induced in all pups. These animals were then divided into two groups: in the first group (experimental), captopril 35 mg/kg/day, dissolved in drinking water, was administered for 6 weeks. The second group (positive control) did not receive any treatment. After 6 weeks all dogs underwent left nephrectomy. Volume fraction and absolute volume of the histological kidney parameters, i.e., normal glomerulus, normal tubule, vessels, degenerated glomerulus, degenerated tubule, fibrous tissue, were estimated using modern unbiased stereological methods.
The absolute volume of interstitial fibrosis was lower in the experimental group (PUO with captopril treatment) (approximately 73%; p < 0.008) in comparison with positive control animals (PUO with no treatment). The mean absolute volume of normal tubules in the experimental group was more than the positive control group (approximately 33%, p < 0.008). The mean absolute volume of normal and degenerated glomerulus, vessels and degenerated tubule did not show a significant difference between the two groups.
Administration of captopril decreases interstitial renal fibrosis and preserves renal tubules in neonatal dogs with PUO.
AuthorsMehdi Shirazi, Ali Noorafshan, Mohammad Arabzadeh Bahri, Nader Tanideh
JournalUrologia internationalis (Urol Int) Vol. 78 Issue 2 Pg. 173-7 ( 2007) ISSN: 0042-1138 [Print] Switzerland
PMID17293660 (Publication Type: Journal Article)
Copyright2007 S. Karger AG, Basel
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Captopril
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Animals
  • Animals, Newborn
  • Captopril (therapeutic use)
  • Dogs
  • Fibrosis (etiology, prevention & control)
  • Kidney (drug effects, pathology)
  • Kidney Tubules (drug effects)
  • Urethral Obstruction (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: